Alexander Rotenberg
Principal investigator, leads GALIBRA NEUROSCIENCE, INC..
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2025First federal award
$500KFederal grants as PI1 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
1 awards · $500K
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 12, 2025 | NIH | STTR Phase I Developing Brain Penetrable AAV Gene Therapy for Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD) | $500K | GALIBRA NEUROSCIENCE, INC. |
Peer ranks
Federal funding#2,408
Awards as PI#2,176
Patents#273
Companies
- GALIBRA NEUROSCIENCE, INC.Leads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.